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Abstract 
Background: Early onset peritonitis (EOP) is not uncommon in peritoneal dialysis patients. We aimed to compare the 
prognosis of EOP and non-EOP peritoneal dialysis patients.
Methods: This study included subjects that underwent PD from January 1, 2004 to July 31, 2013. Patient charac-
teristics were collected. EOP was defined as peritonitis occurring within 6 months after initiation of PD. Patient and 
technique survival were compared between EOP and non-EOP patients using Cox regression analyses.
Results: In total, 189 subjects were included in this study. Patients were divided into EOP (n = 55) and non-EOP 
groups (n = 134). There was no significant difference in the causative organisms of peritonitis between the two 
groups. After adjusting for age, diabetes status, serum albumin level and residual renal function, the multivariable 
Cox regression model revealed that EOP was an independent risk factor for patient mortality (HR 2.03, RI 1.09–3.80, 
p = 0.026), technique failure (HR 1.69, RI 1.12–2.87, p = 0.015) and total survival (HR 1.73, RI 1.12–2.68, p = 0.013).
Conclusions: EOP was identified as an independent risk factor for mortality and technique failure in peritoneal dialy-
sis patients.
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Background
Peritoneal dialysis (PD) is a well-established treatment for 
end-stage renal disease (Li and Chow 2013; Mujais and 
Story 2006; Pecoits-Filho et  al. 2007). Due to improve-
ments in connectology, peritonitis, a common and seri-
ous complication of PD, has decreased dramatically (Daly 
et al. 2001, 2014). Over the past several decades, the role 
of peritonitis as an independent risk factor for mortality 
and technique failure in PD patients has been well estab-
lished (Brown et  al. 2007; Davenport 2009; Fried et  al. 
1996; Kavanagh et al. 2004; Mizuno et al. 2011). However, 
recent studies on this topic have shown contradictory 
results (Fang et al. 2008; Isla et al. 2014).
Peritonitis occurs more frequently in newly initiated 
PD patients because of unskilled PD manipulation. In 
the BRZPD study (Martin et  al. 2011), the median time 
from PD initiation to first peritonitis episode was found 
to be 6 months. Another study also showed that during 
the first year after PD, more than 70  % of patients had 
their first peritonitis episode within 6  months (Pulliam 
et al. 2014). A recently published study reported that the 
first peritonitis episode can change peritoneal membrane 
function. Several studies have already been conducted to 
assess the impact of early onset peritonitis (EOP) on out-
comes in PD patients. EOP has not been defined consist-
ently, with definitions varying from 3 to 24 months after 
PD commencement (Fourtounas et al. 2006; Harel et al. 
2006; Hsieh et  al. 2014). Additionally, previous results 
were not convincing due to the absence of significant 
findings in and relatively small sample sizes of these stud-
ies (Fourtounas et al. 2006; Harel et al. 2006).
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In summary, the definition of early onset peritonitis 
remains controversial. Furthermore, the impact of early 
onset peritonitis on the prognosis of PD patients is still 
without conclusive evidence. In this study, we defined 
peritonitis occurring within 6 months after PD initiation 
as EOP. We aimed to compare the prognosis of EOP and 
non-EOP peritoneal dialysis patients.
Subjects and methods
Patients
This was a retrospective study including all patients in 
our unit who initiated PD between January 1, 2004, and 
July 31, 2013. All patient outcomes were followed-up up 
until July 30, 2014. All patients had double cuff silastic 
PD catheters placed using sterile surgical techniques. 
Patient demographics, etiology of ESRD and PD duration 
were obtained by review of patient charts and the com-
puterized database in our unit. Patients were followed 
until transfer to hemodialysis, renal transplantation or 
death. Death during PD or within 1 month after conver-
sion to HD was regarded as PD-related mortality. Clinical 
outcomes were mortality and technical failure. Patients 
who transferred to HD were censored from patient sur-
vival analysis, while patients who died were censored 
from analysis of technique failure. Exclusion criteria 
were as follows: (1) PD duration of less than 3  months, 
(2) inadequate clinical follow-up information, (3) renal 
transplantation, and (4) prior history of hemodialysis. 
The study protocol was approved by the ethics commit-
tee of our institution.
Diagnosis of early onset peritonitis
Peritonitis was diagnosed in accordance with published 
guidelines from the International Society of Peritoneal 
Dialysis and according to the following standard criteria: 
clinical signs of peritoneal inflammation, positive culture 
of peritoneal fluid, and cloudy dialysate with an elevated 
dialysate white blood cell count of more than 100/mm3 
(Li et  al. 2010). Early onset peritonitis was defined as 
peritonitis occurring within 6 months of PD initiation.
Treatment of peritonitis
All patients were assessed by PD unit/renal ward nurses 
and reviewed by a physician at diagnosis. Empiric treat-
ment consisted of intraperitoneal cefathiamidine (2  g/
day) and etimicin (200  mg/day). Antibiotic treatment 
was tailored once antimicrobial sensitivities were avail-
able. The standard duration of antibiotic treatment was 
2  weeks. Treatment for longer than 2  weeks was left 
to the discretion of the physician. PD catheters were 
removed and patients were switched to hemodialysis if 
they demonstrated a lack of improvement within the first 
week of appropriate antibiotic therapy or culture results 
indicated fungal infection.
Collecting of clinical characteristics
Data for all subjects during their following up period, 
including age; gender; serum albumin, creatinine, cal-
cium, and phosphate levels; KT/V; and residual renal 
function were collected from our center. All perito-
nitis episodes were recorded, and for each peritonitis 
episode, the causative microorganism was recorded, if 
isolated.
Statistical analysis
Continuous variables are presented as the mean  ±  SD, 
and categorical variables are expressed as percentages 
unless otherwise stated. For comparisons of continuous 
variables between two groups, Student’s t test was used. 
Correlations were tested using the Pearson correlation 
method. The Kolmogorov–Smirnov test was used to 
analyze the distribution of continuous data for the pres-
ence of a normal distribution. Relationships between 2 
or more groups of data were analyzed using the Pearson 
Chi square test. Survival curves were generated using the 
Kaplan–Meier method and compared using the log-rank 
test. Factors predictive of patient and technique survival 
were identified using Cox regression analyses. Factors 
with p < 0.10 in univariate analyses were entered into a 
multivariate Cox regression model. A backward elimina-
tion procedure with a removal criterion of p > 0.05 was 
performed to identify independent predictors of patient 
and technique survival. All computations were per-
formed using SPSS 17.0 for Windows (SPSS Inc, Chicago, 
IL, USA), and p < 0.05 was considered statistically signifi-
cant (Figs. 1, 2, 3).   
Results
During the study period, 474 subjects were referred to the 
dialysis center. Fourteen patients underwent renal trans-
plantation. Twenty-one subjects died within 3 months of 
PD initiation. Twenty-eight patients were transferred out 
of the unit, and the other three patients exhibited renal 
function recovery. Thus, 189 patients had at least one 
episode of peritonitis.
Patient characteristics
Of the study subjects, 43.9 % were female (n =  83) and 
56.1 % were male (n = 106). The mean age of the subjects 
was 57.5 ±  15.9  years. The mean duration of treatment 
was 32.4 ± 23.1 months (range 3–88 months). Additional 
demographic characteristics, etiology of ESRD, comorbid 
conditions and laboratory characteristics of the patients 
are shown in Table 1.
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Organisms causing peritonitis in EOP and non‑EOP 
patients
In total, 271 peritonitis episodes occurred in 189 
patients, and the peritonitis rate was 42.1 episodes per 
patient-month. The mean peritonitis-free period was 
22  ±  15  months. During the study period, 69 (36.5  %) 
patients had more than 1 episode of peritonitis. Fifty-five 
(29.1  %) patients were diagnosed with EOP. Peritonitis 
episodes occurred more frequently in EOP patients (28.7 
episodes per patient-month) than in non-EOP patients 
(49.4 episodes per patient-month).
The culture positive rate was 80.3  %. Comparisons of 
the culture results between the two groups are shown in 
Table 2. The organisms causing peritonitis did not differ 
significantly between the two groups.
Causes of death and technique failure
In total, 59 and 84 subjects died in the non-EOP and EOP 
groups, respectively. Twenty-nine non-EOP and 44 EOP 
patients died as a result of cardiovascular events; these 
events included cardiac arrest (n =  7 and n =  8 in the 
non-EOP and EOP groups), acute myocardial infarction 
(n = 6), cardiac arrhythmias (n = 5), heart failure (n = 5 
and n = 11 in the non-EOP and EOP groups), and stroke 
(n = 6 and n = 16 in the non-EOP and EOP groups). Fif-
teen subjects died of infection, of whom 6 died of peri-
tonitis, 6 died of pneumonia, and 3 died of sepsis. The 
other 15 subjects died of cachexia (n =  5), gastrointes-
tinal bleeding (n = 3), malignancy (n = 3) and unknown 
reasons (n =  4). Thirty-six subjects were transferred to 
hemodialysis. The most common cause for this transfer 
was peritonitis (n  =  16), including refractory peritoni-
tis (n = 6), recurrent peritonitis (6) and fungal peritoni-
tis (n =  4). Other causes included ultrafiltration failure 
(n = 10), refractory heart failure (n = 8) and tunnel infec-
tion (n = 3).
Comparison of outcome in EOP and non‑EOP groups
As is shown in Table 3, age, comorbid diabetes mellitus, 
serum albumin level, CRP, RRF and EOP were univari-
ately associated with mortality in PD patients. In the mul-
tivariate Cox regression model, EOP was an independent 
risk factor for patient mortality (HR 2.03, RI 1.09–3.80, 
p  =  0.026), technique failure (HR 1.69, RI 1.12–2.87, 
p  =  0.015) and total survival (HR 1.73, RI 1.12–2.68, 
p = 0.013).
Fig. 1 Patient and technique survival in EOP and non-EOP group
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Discussion
In this study, we determined that EOP occurred in 
approximately one-third of peritonitis patients. We also 
confirmed that EOP was an independent risk factor for 
poorer outcomes in PD patients.
The definition of early onset peritonitis remains con-
troversial. The BRAZPD study revealed that the median 
time to first peritonitis episode in elderly PD patients 
was 6  months (Martin et  al. 2011). In a recently pub-
lished study of 1677 incident peritoneal dialysis patients 
in America, three-fourths of patients exhibited a first 
peritonitis episode within the first 6  months of perito-
neal dialysis treatment (Pulliam et al. 2014). In our study, 
one-third of peritonitis episodes occurred during the first 
6  months after PD initiation. Based on these observa-
tions, it is reasonable to use 6 months as the cut-off point 
to define early peritonitis.
In this study, we found that gram-positive and gram-
negative bacteria were the causative organisms in 54.5 
and 23.8  % of peritonitis cases, respectively. The most 
common bacteria causing the first peritonitis episode 
was Staphylococcus aureus. This result is in accordance 
with research conducted by Fourtounas et  al. (2006), 
Hsieh et al. (2014). The organisms implicated in causing 
EOP and late onset peritonitis did not differ significantly 
(Table 2). However, peritonitis rates were higher in EOP 
patients than in patients with late onset peritonitis. 
This may because of unskilled manipulation after PD 
(Fourtounas et al. 2006).
This research found that EOP was an independent risk 
factor for poorer outcomes in PD patients. This result is in 
accordance with previous studies on this topic (Isla et al. 
2014; Kavanagh et  al. 2004; Li and Chow 2013). There 
are several explanations for this result. First, peritonitis 
has been confirmed to be an independent risk factor for 
poor outcomes in PD patients. In this study, patients with 
EOP had increased peritonitis rates. Fourtounas et  al. 
(2006) also reported this phenomenon. Moreover, studies 
have reported that peritonitis can alter natural peritoneal 
membrane characteristics and cause long-lasting altera-
tions in peritoneal transport states (Radtke et al. 2004; van 
Diepen et al. 2014), which may result in poor outcomes. 
Second, patients with EOP may have poor nutritional sta-
tus. In this study, compared to non-EOP patients, EOP 
patients were older and had a lower ALB level, both of 
which may negatively impact patient outcomes.
We defined EOP as peritonitis occurring within 
6  months after PD initiation. This is different from 
Fig. 2 Patient survival in EOP and non-EOP group
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Fig. 3 Technique survival in EOP and non-EOP group
Table 1 Comparison of characteristics in EOP and non-EOP 
patients
EOP early onset peritonitis, BMI body mass index, CRP C-reactive protein, RRF 
residual renal function
Clinical parameters Non‑EOP (n = 134) EOP (n = 55) p value
Age (years) 56.9 ± 15.8 60.8 ± 16.1 0.092
Gender (male/female) 201/151 29/26 0.543
BMI (kg/m2) 22.8 ± 3.7 23.1 ± 4.3 0.361
Diabetes [n (%)] 83 (23.6) 14 (25.5) 0.761
Etiology of ESRD [n (%)] 0.712
 Primary glomerulone-
phritis
81 (60.4) 29 (52.7)
 Diabetic nephropathy 21 (15.7) 8 (14.5)
 Hypertensive 
nephropathy
15 (11.2) 9 (16.4)
 Other 17 (12.7) 9 (16.4)
Serum albumin (g/dl) 3.1 ± 0.6 2.8 ± 0.6 0.002
Hemoglobin (g/dl) 10.4 ± 2.0 10.6 ± 2.1 0.576
Phosphorus (mmol/l) 1.57 ± 0.46 1.45 ± 0.38 0.08
Calcium (mmol/l) 2.11 ± 0.25 2.08 ± 0.19 0.434
CRP 4 (4,13) 4 (4,21) 0.632
KT/V urea 1.92 ± 0.51 1.87 ± 0.29 0.603
RRF (ml/min/1.73 m2) 0.62 ± 0.41 0.67 ± 0.46 0.521
Table 2 Comparison of  orgnisms in  causing first peritoni-
tis in EOP and non-EOP patients
EOP early onset peritonitis
Clinical parameters EOP (n = 55) Non‑EOP (n = 134) p value
Gram-positive organisms 30 75 0.915




 Streptococcus species 3 7
 Enterococcus species 3 6




 Escherichia coli 4 13
 Klebsiella species 4 10
 Serratia species 1 5
 Acinetobacter species 1 4
 Other gram-negatives 1 3
Fungi 1 3 0.995
Culture negative 13 21 0.344
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research conducted by Hsieh et  al. (Fourtounas et  al. 
2006; Hsieh et al. 2014). In their study, using the median 
duration to peritonitis, they defined peritonitis occurring 
within 24 months as EOP. Thus, their definition may not 
be generalizable to other patient populations, affecting 
study results. In this study, approximately 30 % of subjects 
were diagnosed with EOP. This result is in accordance 
with research conducted by Martin et al. (2011) and Pul-
liam et al. (2014), supporting our definition of EOP. Fur-
thermore, early diagnosis of EOP may be associated with 
earlier intervention and, therefore, improved prognosis.
In this study, we also demonstrated that older age, 
lower albumin level, diabetes diagnosis and residual renal 
function were risk factors for patient mortality and tech-
nique failure. These risk factors have already been well 
established in several large prospective studies (Collins 
et al. 1999; Vonesh and Moran 1999; Wang et al. 2004).
There are several limitations to our study. First, a limita-
tion of this study is that it was conducted in a single center. 
Second, due to the retrospective nature of this study, some 
potentially important characteristics, such as literacy and 
SGA and comorbidity index scores, were not evaluated.
Conclusions
In conclusion, our study demonstrates that EOP has a 
negative effect on outcomes in PD patients. To confirm 
this relationship, clarify its underlying mechanisms, and 
identify risk factors for EOP in CAPD patients, a pro-
spective study needs to be conducted.
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